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Arbovirus inhibition phenotype
Arboviruses transmitted by mosquitoes have great 
importance in global health, owing to increasing 
ranges and impact and often with no effective vac-
cines or reliable prophylactics available. The most 
important is the flavivirus dengue virus (DENV), 
which occurs in 100 countries and causes tens 
of millions of cases of dengue fever annually, 
approximately half a million of which proceed 
to life-threatening hemorrhagic fever or shock 
syndrome [1]. Chikungunya virus (CHIKV), 
an alphavirus, is an important emerging patho-
gen in many regions of the world, and a number 
of epidemics with tens of thousands of cases or 
more have occurred in the last decade [2]. A dra-
matic transmission-blocking phenotype (e.g., no 
infectious viral particles could be detected in the 
mosquito saliva) for both viruses was observed 
in the mosquito Aedes aegypti, the most impor-
tant vector of DENV. This vector was artificially 
transinfected with the wMelPop and wMel strains 
of the bacterial endosymbiont Wolbachia from 
Drosophila melanogaster [3–5]; inhibition of yellow 
fever virus was also observed in wMel-infected 
Ae. aegypti [5]. A wMel transinfection in Aedes 
albopictus blocked the laboratory transmission 
capacity for DENV [6] and CHIKV [7]. This 
species is often considered a secondary vector of 
DENV, although it has been the primary or sole 
vector in a number of epidemics, and is frequently 
a primary vector of CHIKV following an envelope 
protein mutation that significantly and specifi-
cally increased viral fitness in Ae. albopictus [8,9]. 
Interestingly, Wolbachia can also inhibit the trans-
mission of some mosquito-borne parasites, such as 
Plasmodium by Ae. aegypti [3].
Wolbachia are intracellular and tend to be most 
concentrated in reproductive organs, but often 
have a wide tissue distribution within the host 
insect, including midgut and salivary glands. 
Arboviruses acquired in the blood meal must 
invade midgut cells and ultimately disseminate to 
the salivary glands to be transmitted, so Wolbachia 
and the virus can potentially be present within the 
same cells. Wolbachia itself is not an infectious 
agent, but is maternally transmitted in the egg 
cytoplasm and is able to invade host populations 
by manipulating their reproduction. The most 
widely observed reproductive phenotype (and the 
only one observed in mosquitoes) involves cross-
ing sterilities known as cytoplasmic incompatibil-
ity. In the simplest case, consider crosses between 
Wolbachia-infected and uninfected individuals, 
early embryonic arrest occurs when uninfected 
females mate with infected males [10]; however, 
the offspring of infected females develop normally 
regardless of the male infection status, thus giving 
infected females a reproductive advantage. The 
self-spreading ability of Wolbachia makes it an 
attractive biocontrol agent to interrupt or reduce 
arbovirus transmission. A first field trial target-
ing wild populations of Ae. aegypti in northern 
Australia has proven successful in introducing the 
wMel strain to high population frequency [11].
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is important in order to make informed predic-
tions of the selective forces that will operate on 
the virus and mosquito that might ameliorate 
the inhibition phenotype over time, and thus 
how to maximize the effectiveness and longevity 
of the strategy. What is known so far and what 
hypotheses can be generated regarding how the 
viral inhibition phenotype works (Figure 1) will 
be considered here, together with the effects of 
different Wolbachia strains on host fitness, which 
is an important factor with respect to Wolbachia 
population invasion dynamics.
Strain specificity of viral inhibition 
& Wolbachia density
The viral inhibition phenotype is Wolbachia 
strain-dependent, and there is also an effect of 
host species on the degree of inhibition afforded. 
Wolbachia is naturally present in many mosquito 
species. Wild Ae. albopictus individuals usually 
carry two strains of the bacterium [12], wAlbA 
and wAlbB, and a modulating effect on trans-
mission capacity has been reported for DENV 
compared with antibiotic-treated Wolbachia-free 
mosquitoes of this species [13]; although, this 
difference was not apparent in all experiments 
and was much more modest than that observed 
when wMel strain Wolbachia was introduced [6]. 
Interestingly, high experimental CHIKV titers 
produced a reduction in density of wild-type 
wAlbA and wAlbB Wolbachia in Ae. albopic-
tus [14], which suggests resource competition 
between bacteria and virus. When the wAlbB 
strain was transferred from Ae. albopictus into 
Ae. aegypti, stronger inhibition of DENV mid-
gut replication and subsequent dissemination to 
thorax and head was observed compared with 
in the natural host [15]; however, the degree of 
inhibition was still lower than that produced 
by the wMelPop transinfection in Ae. aegypti 
[3]. In addition wild-type Culex quinquefas-
ciatus, carrying the wPip-strain of Wolbachia, 
showed reduced dissemination of West Nile 
virus (WNV) when compared with an unin-
fected, antibiotic-cured line. WNV is a zoo-
notic flavivirus causing increasing numbers of 
cases of human encephalitis, which is endemic 
in Africa, Europe, central Asia and Australia, 
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Figure 1. Some of the interactions between high-density Wolbachia infections and dengue 
virus in mosquito cells that could contribute to the arbovirus inhibition phenotype. 
Interactions that are more uncertain in terms of the effects or direction are shown as hatched lines. 
Oxidative stress was induced by the presence of high densities of Wolbachia. 
DENV: Dengue virus; FASN: Fatty acid synthase; RC: Viral replication complex; ROS: Reactive oxygen 
species.
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and has recently expanded its range into North 
America [16].
A number of studies have now shown that the 
transinfecting Drosophila strains of Wolbachia 
reach higher densities in mosquitoes than the 
naturally occurring mosquito Wolbachia infec-
tions, and there is evidence that high density 
is causally linked to the virus inhibition phe-
notype. A direct comparison of wMel and 
wild-type wAlbA/wAlbB in Ae. albopictus, in a 
genetically homogenous background, showed 
approximately a tenfold higher overall density 
reached by wMel [6]. An association of degree 
of inhibition of viral replication with bacterial 
density or load was observed in cell lines for 
both DENV and WNV [17–19]. In wMelPop-
infected Ae. aegypti challenged with DENV, 
a nonoverlapping distribution of bacterial and 
viral particles was reported within tissues, sug-
gesting a cell-autonomous antiviral effect [3]. In 
parallel studies in D. melanogaster and Drosoph-
ila simulans, some but not all Wolbachia strains 
provided protection against pathogenic viruses 
such as DCV (associated with a reduction in 
viral titers) and also flock house virus and Nora 
virus (not associated with a decrease in viral 
titers); only the higher density Wolbachia strains 
afforded virus protection [20–23]. Indeed, when 
the density of one of the strains showing high 
viral protection was reduced using antibiotics to 
levels similar to that of the nonprotective strains, 
the viral protection phenotype was lost [23]: this 
provides direct evidence of the importance of 
bacterial density to the phenotype.
Mosquito innate immune pathways
The transinfection of wMelPop Wolbachia in 
Ae. aegypti produced a chronic, major upregu-
lation of a number of immune genes, includ-
ing components of the Toll, Imd, Jak–Stat and 
melanization pathways and their effectors, such 
as cecropins and defensins, and thioester-con-
taining proteins [3,24]. Lower level upregulation 
of selected immune genes was observed for the 
wAlbB transinfection in Ae. aegypti [16]. The Toll 
pathway in particular is known to be activated 
in mosquitoes by DENV and to modulate the 
replication of the virus. In addition, the presence 
of the gut microbiota influences viral infection 
levels via basal Toll pathway immune activation 
[25]. The activation of the Ae. aegypti Toll path-
way in the line transinfected with wAlbB, has 
been reported to be mediated through the pro-
duction of reactive oxygen species and activation 
of the NADPH oxidase, resulting in upregula-
tion of Toll pathway cecropins and defensins. It 
has been demonstrated using knockdowns and 
transgenic lines that levels of these antimicrobial 
peptides can influence DENV titers [26]. Thus, 
the presence of Wolbachia in Ae. aegypti can 
allow the primed mosquito immune system to 
eliminate virus particles more effectively. It also 
seems likely that the enhanced immune response 
allows more efficient killing of parasites, such as 
filarial nematodes and Plasmodium [24,27].
However, in an Ae. albopictus line transin-
fected with wMel, a selection of orthologs of 
immune effector genes that were upregulated 
in the presence of Wolbachia in Ae. aegypti, 
including a cecropin and defensin, were not 
significantly upregulated at generation ten [6]. 
Given that this mosquito naturally carries Wol-
bachia, it would seem that a long evolutionary 
history of association has modulated its immune 
response, even to a non-native strain such as 
wMel. Whether or not the host naturally harbors 
Wolbachia appears to be the important factor in 
the different immune pathway responses, rather 
than the differing densities reached by natural 
versus transinfecting strains. While the involve-
ment of immune genes in virus inhibition has 
not been ruled out, since an exhaustive screen 
has not yet been carried out for this Ae. albop-
ictus transinfection, it does appear that other 
factors beyond the mosquito innate immune sys-
tem are primarily responsible for the blockage of 
DENV and CHIKV transmission (whereby no 
infectious viruses were detected in the saliva) in 
Ae. albopictus; Wolbachia strain type and density 
reached are the important factors here. In paral-
lel, the low or insignificant induction of AMPs 
and other Toll and Imd pathway immune genes 
observed in Wolbachia-infected Drosophila [28,29] 
has suggested that other mechanisms beyond the 
canonical immune pathways must be operating 
to provide viral protection. 
The mosquito antiviral RNA interference 
response has been shown to be a significant 
determinant of the efficiency of DENV trans-
mission by Ae. aegypti [30]. However, the pres-
ence of Wolbachia reduces DENV replication in 
the Ae. albopictus C6/36 cell line [17], and this 
cell line shows an impaired RNA interference 
antiviral response, lacking functional Dicer-2 
expression [31], suggesting that this pathway 
of viral defense is unlikely to be an important 
component of the phenotype [32]. 
Autophagy, lipid metabolism 
& cholesterol
Autophagy is the essential and ubiquitous lyso-
somal degradation pathway by which eukaryotic 
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cells dispose of organelles and large protein aggre-
gates, especially in times of stress and starvation, 
and for recycling cellular components during 
development. It is also used to degrade bacte-
ria, viruses and protozoan parasites that invade 
cells, and the autophagy machinery thus inter-
faces with innate immune response pathways 
[32]. Despite its antiviral functions as a branch 
of the immune system, autophagy can also be 
subverted by some viruses to perform proviral 
roles. DENV has been shown to both induce 
and require autophagy for robust viral replication 
in mammalian cells [33,34], specifically of a form 
of autophagy that is targeted to lipid droplets, 
producing changes in the metabolism of the cell. 
The DENV-induced autophagosomes colocalize 
with lipid droplets and become autolysosomes, 
leading to a release of free fatty acids. DENV 
replication inhibition, caused by inhibition of 
autophagy, is rescued by the addition of free 
fatty acids with b-oxidation; thus, this pathway 
is believed to provide a favorable environment 
for viral replication by generating energy [35,36]. 
CHIKV has likewise been shown to activate 
autophagy, and this process promotes its replica-
tion [37]. Lipid droplets have also been proposed 
to be involved in DENV particle assembly [38]. 
The intracellular bacterium Anaplasma 
phagocytophilum, which is related to Wolbachia, 
secretes a protein that hijacks the autophagy 
initiation pathway, probably as a mechanism to 
acquire host nutrients [39]. It has recently been 
demonstrated that a protein that provides a 
marker of activation of autophagy, ATG8a, is 
abundant in Brugia tissues in which Wolbachia 
is abundant. In addition, autophagy activation 
using rapamycin can reduce Wolbachia density 
in Ae. albopictus cells [40]. Experiments are now 
needed to determine the ways in which Wolba-
chia may modulate autophagy to establish its 
intracellular niche, and whether that modulation 
could influence arboviral interactions with the 
autophagy pathways. Autophagy is a complex 
process and it is possible that the autophagy-
related interactions of these viruses observed so 
far in mammalian cells will prove to be specific 
to the mammalian host. Experiments investi-
gating how DENV and CHIKV may modulate 
autophagy in mosquito cells are now needed.
Intracellular membranes are modified by 
DENV to form the sites of viral replication com-
plexes, and the virus makes significant modifi-
cations to the lipid repertoire of infected mos-
quito cells [41]. DENV has been shown to co-opt 
the fatty acid biosynthetic pathway, increasing 
the rate of biosynthesis, for this purpose. Fatty 
acid synthase, a key enzyme in the pathway, 
is required by the virus and is localized to the 
sites of DENV replication in both mammalian 
[35] and mosquito cells [41]. Wolbachia requires 
unsaturated fatty acids from host cells, since it 
lacks fatty acid desaturation genes, and at high 
bacterial densities fatty acid depletion could rep-
resent a cellular perturbation that disturbs the 
viral manipulation of these pathways. DENV 
replication is also modulated by cholesterol bio-
synthesis [42], and alphaviruses such as CHIKV 
also require cholesterol and sphingolipids for 
optimal endosomal fusion [43]. Cholesterol 
is obtained by insects from their diet and is a 
limiting resource. Wolbachia, like Anaplasma, 
lack genes for lipopolysaccharide biosynthesis, 
so may need to incorporate cholesterol derived 
from host cells into their membranes to ensure 
their integrity. It has therefore been hypoth-
esized that the presence of Wolbachia at high 
densities in relevant tissues could inhibit these 
viruses by depleting cholesterol levels, through 
direct intracellular competition for this resource 
[3]. Experimental testing of this hypothesis is 
needed. 
Strain density & host fitness 
The dynamics of Wolbachia population replace-
ment using cytoplasmic incompatibility as a dis-
ease biocontrol strategy depend in part on any 
fitness costs of transinfecting Wolbachia strains, 
which will raise the unstable equilibrium fre-
quency that represents a threshold that must be 
exceeded for spread to occur. Full characteriza-
tion of the comparative fitness of each transinfec-
tion is of fundamental importance in determin-
ing which strains should be used for biocontrol, 
and to optimize efficiency. The viral inhibition 
phenotype itself is unlikely to provide any major 
selective advantages with respect to protection 
from arboviruses, such as DENV, which do 
not impose major fitness costs on the mosquito 
[44]. The extent of any fitness advantages that 
could be accrued through protection from other 
mosquito pathogens is largely unknown. 
In Ae. aegypti, the high density wMelPop strain 
is virulent and approximately halves the lifespan 
of the Ae. aegypti host [45,46]. This life-shortening 
is advantageous with respect to disease control, 
since a viral extrinsic incubation period is required 
within the mosquito before it becomes infectious, 
such that reducing the proportion of older females 
will have a disproportionate effect in reducing 
virus transmission [45]. In theory wMelPop could 
still spread through populations if fitness costs 
are primarily incurred by older individuals, 
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since most reproduction is undertaken by young 
females in nature, only a minority would live long 
enough for the additional fitness load imposed 
by wMelPop to have a significant negative effect. 
Indeed, invasion of cage populations of Ae. aegypti 
by wMelPop has been documented [4]. However, 
the wMelPop transinfection also decreased the 
viability of stored Ae. aegypti eggs over time [5,47]. 
Desiccated eggs often play an important role in 
population maintenance during dry periods, so 
this could be an important impediment to popu-
lation spread. Female feeding was also negatively 
affected in some individuals, primarily (but not 
only) in older wMelPop-infected females, with 
a ‘bendy proboscis’ phenotype and difficulty in 
completing the process of blood feeding effec-
tively (i.e., smaller blood meals taken and lower 
saliva volumes) [48,49]. Susceptibility to predation 
(using six different predator types) was not, how-
ever, significantly increased in laboratory tests of 
wMelPop-infected individuals compared with 
uninfected wild-types [50].
The wMel transinfection is considerably more 
benign in Ae. aegypti in the laboratory [4], with-
out a significant life-shortening phenotype, and 
its successful introduction into wild populations 
of Ae. aegypti confirmed its utility under natural 
conditions [5]. Male mating competitiveness was 
not found to be significantly impaired by either 
the wMel or the wMelPop transinfection in lab-
oratory cage challenges [51]. Assuming the viral 
inhibition phenotype produced by wMel remains 
as strong in natural populations as in laboratory 
challenges, then it will clearly be preferable to use 
this strain for control of disease transmission by 
Ae. aegypti over wMelPop. In Ae. albopictus the 
difference was even more pronounced: greatly 
reduced hatch occurred in eggs laid by females 
transinfected with wMelPop [52], likely to preclude 
its use for disease control in this species. However, 
replacing the wild-type wAlbA + wAlbB infec-
tion in Ae. albopictus with wMel did not produce 
significant reductions in egg hatch from tran-
sinfected females, and no major fitness costs in 
laboratory cage assays of fecundity, longevity and 
relative male mating competitiveness [7].
The fitness effects of different Wolbachia 
strains show a correlation with the overall density 
reached; however, more specifically, there could be 
differences in fitness costs even where the overall 
density reached is similar, according to the range 
of tissues that are colonized by different strains; 
for example, the degree of proliferation in nervous 
tissues. It is possible that there may prove to be 
trade-offs between the density reached by differ-
ent strains, degree of viral inhibition achieved 
under field conditions and fitness costs. It is also 
important to note that strategies for using Wol-
bachia in disease control, even strains that cause 
fitness costs, and thus have higher threshold 
release frequencies that must be exceeded, can 
be designed to reduce the population of biting 
females at the same time. Male-biased releases, 
where these males are incompatible with wild 
females [53], can be achieved by pupal size sorting.
Conclusion & future perspective
It is likely that a much better understanding 
of the mechanisms of Wolbachia inhibition in 
mosquitoes will soon emerge, as experiments to 
manipulate various genes and cellular pathways 
are undertaken. There is already evidence that 
more than one factor can contribute to the phe-
notype; innate immune effector upregulation 
can reduce viral replication in Ae. aegypti, but in 
other systems it is not required for strong virus 
inhibition to occur. Thus it will be important to 
not generalize between Drosophila models and 
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mosquitoes, or between mosquito species, which 
differ in their immune response to Wolbachia, or 
between different viruses given the complexity of 
viral cellular interactions with the host. Cell lines 
have a useful role to play in these experiments as 
simplified model systems; in some cases, lacking 
functional immune pathways. Regulation of lipid 
metabolism is an important component of DENV 
and CHIKV replication, and investigations of the 
effects of Wolbachia on these processes are needed 
in mosquitoes. Viruses can also modulate or usurp 
a range of other host cell functions to facilitate 
their replication (for example, the suppression of 
apoptosis), and Wolbachia may do likewise. A bet-
ter understanding of these interactions could pro-
vide new hypotheses for the inhibition phenotype. 
There is also emerging evidence that the presence 
of Wolbachia changes transcription levels of a 
host miRNA, and consequently a methyltrans-
ferase gene in Ae. aegypti. In addition, levels of 
expression of methyltransferase could have some 
influence on DENV replication [54]. Research is 
needed to determine to what extent this could 
contribute to arboviral inhibition phenotypes.
The extension of initial open field release tri-
als to other Ae. aegypti populations and into 
Ae. albopictus will give a much more complete 
understanding of the utility of this system for 
disease control, in particular whether complete 
viral inhibition is always maintained under field 
conditions and whether the phenotype might be 
modulated over time. Wolbachia could be used for 
the control of other arboviruses if transinfections 
also cause strong inhibition, such as WNV, the 
encephalitis viruses (Japanese encephalitis, eastern 
equine encephalitis, Venezuelan equine encepha-
litis, Saint Louis encephalitis  and Murray Valley 
encephalitis), Rift Valley fever, Ross River virus 
and Sindbis. All have multiple mosquito vectors 
and it is unlikely that it will be possible to prevent 
transmission by them all, given that Wolbachia is 
solely maternally transmitted and creating tran-
sinfections by embryo microinjection and selec-
tion is a challenging and labor-intensive process. 
However, individual important vector species pro-
vide attractive potential targets, such as members 
of the Aedes scutellaris group (regional vectors of 
DENV and CHIKV), and Culex species such as 
Culex quinquefasciatus (WNV and others) and 
Culex triteaniorhynchus (Japanese encephalitis 
virus). Laboratory cage studies, field cage trials 
and, most usefully, open field release studies will 
give the best indication of population dynamics 
of transinfections and their effectiveness for arbo-
virus control. Where there are trade-offs between 
high-density Wolbachia infections needed to pro-
duce strong viral inhibition, and fitness costs that 
may be imposed by the highest Wolbachia loads, 
the strain–host combinations most useful for 
arbovirus control will balance these factors.
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